Phibro Animal Health reported $373.91M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Align Technology USD 1.02B 40M Sep/2026
ANI Pharmaceuticals USD 290.77M 24.77M Sep/2026
Aurora Cannabis CAD 67.55M 29.54M Jun/2026
Bristol-Myers Squibb USD 13.07B 100M Sep/2026
Canopy Growth CAD 81.16M 9.91M Jun/2026
Corcept Therapeutics USD 340.5M 84.35M Sep/2026
Eli Lilly USD 24.4B 1.43B Sep/2026
Henry Schein USD 3.47B 10M Sep/2026
Idexx Laboratories USD 1.21B 10M Sep/2026
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Merck USD 18.1B 1.5B Sep/2026
Nektar Therapeutics USD 10.86M 10.95M Mar/2026
Pacira USD 176.65M 15.75M Sep/2026
Phibro Animal Health USD 373.91M 10.02M Dec/2025
Prestige Brands USD 265.71M 15.91M Jun/2026
Supernus Pharmaceuticals USD 226.8M 7.7M Sep/2026
Zoetis USD 2.4B 100M Sep/2026